Literature DB >> 1562708

Descriptive epidemiology of nasopharyngeal carcinoma in Peninsular Malaysia.

U Prasad1, L Rampal.   

Abstract

Nasopharyngeal carcinoma (NPC) is one of the most common cancers in Malaysia, a country in Southeast Asia with a multiracial population. While hospital-based data on NPC and data from a few states have been reported, a comprehensive study involving every known NPC patient in the whole of Peninsular Malaysia in one particular year had never been done. In the present study, the computed incidence rate was not only adjusted for age, sex, ethnicity, and place of residence, but also direct standardization methods of Rothman and Dever were used to reduce any distortion. The mean age of the 365 new cases of NPC registered in 1988 was 46.8 years (SD +/- 12.2 years). The ages of patients ranged from 10 to 80 years. The incidence in both sexes rose after the age of 20-29 years and reached a plateau between 40 and 49 years. No further rise was exhibited after age 60 years. The Chinese had the highest age-adjusted incidence rates, particularly for the age group 40-49 years, where the incidence rate was 40.1 per 100,000 for males and 14.9 for females. The average age-adjusted male/female ratio was 2.8:1. Age-adjusted incidence varied by place of residence. The pattern that emerged from the data indicated the possibility of interaction between genetic susceptibility and environmental cofactors in the etiology of NPC.

Entities:  

Mesh:

Year:  1992        PMID: 1562708     DOI: 10.1007/bf00051659

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  5 in total

1.  Variations in nasopharyngeal cancer incidence among specific Chinese communities (dialect groups) in Singapore.

Authors:  K Shanmugaratnam
Journal:  IARC Sci Publ       Date:  1978

2.  Nasopharyngeal cancer in Sarawak (Borneo).

Authors:  C S Muir; W F Oakley
Journal:  J Laryngol Otol       Date:  1967-02       Impact factor: 1.469

3.  Incidence of nasopharyngeal carcinoma in Malaysia, 1968--1977.

Authors:  R W Armstrong; M Kannan Kutty; S K Dharmalingam; J R Ponnudurai
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

4.  Cancer in Sabah (Borneo) a prelimanry survey.

Authors:  C S Muir; M D Evans; P J Roche
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

5.  Nasopharynx cancer in Chinese of California.

Authors:  P Buell
Journal:  Br J Cancer       Date:  1965-09       Impact factor: 7.640

  5 in total
  6 in total

1.  An outcome of Surgically Treated Head and Neck Cancer in one of the tertiary Referral Center in the East Coast of Malaysia: A 6-year Retrospective Analysis.

Authors:  Kahairi Abdullah; Raja Ahmad Raja Lope Ahmad; Zamzil Amin Asha'ari; Mohd Sayuti Razali; Wan Islah Leman
Journal:  Malays J Med Sci       Date:  2014-07

2.  Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma.

Authors:  H M Cheng; Y T Foong; A J AbuSamah; J Dillner; C K Sam; U Prasad
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

3.  A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma.

Authors:  A Mathew; H M Cheng; C K Sam; I Joab; U Prasad; C Cochet
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

4.  Corticosteroid Therapy in Optic Neuropathy Secondary to Nasopharyngeal Carcinoma.

Authors:  Zulaikha Wahab; Evelyn Tai; Wan-Hazabbah Wan Hitam; Khairy Shamel Sonny Teo
Journal:  Cureus       Date:  2021-03-06

5.  Descriptive epidemiology of nasopharyngeal carcinoma at Tikur Anbessa Hospital, Ethiopia.

Authors:  Elizabeth Tadesse Beyene; Siraw Girum Ketema; Assaye Nibret Alebachew; Mizan Yeshanew Saleh; Tsigereda Atumo Gebremariam
Journal:  BMC Cancer       Date:  2021-05-12       Impact factor: 4.430

6.  Retrospective Analysis of Cancer Care Performance and Survival Outcome for Nasopharyngeal Carcinoma at a leading Cancer Treatment Centre in Malaysia 2008-2012.

Authors:  Matin Mellor Abdullah; Yoke Ching Foo; Beng Khiong Yap; Catherine May Ling Lee; L P Hoo; Teck Onn Lim
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.